Cardiology and Therapy, 2023 Background Studies evaluating the role of midodrine as an adjunctive therapy to liberate patients with shock from intravenous (IV) vasopressors have yielded mixed results.
Mohamed Hamed +9 more
doaj +2 more sources
Use of midodrine in heart failure: a review
Annals of Medicine & Surgery, 2023 Heart failure is a global health concern, affecting millions of individuals worldwide. Midodrine, an alpha-1 receptor agonist, might be a potential treatment option for patients with heart failure and concurrent hypotension. This review provides a comprehensive summary of the existing literature on the use of midodrine in heart failure patients ...
Gautam, Sudarshan +8 more
openaire +3 more sources
Frontiers in PharmacologyBackground: Heart failure with reduced ejection fraction (HFrEF) poses significant health risks. Midodrine for maintaining blood pressure in HFrEF, requires further safety investigation.
Ming-Ju Wu +8 more
doaj +2 more sources
Failure of pacemaker therapy in a pediatric patient with neurally mediated complete heart block and syncope: A case report [PDF]
Clinical Case ReportsKey Clinical Message Neurally mediated syncope (NMS) is a well‐known condition that can be subdivided into three subgroups: vasopressor type, cardioinhibitory type, and mixed type. While different degrees of sinus bradycardia occur at the time of syncope
Mohammad Dalili, Feisal Rahimpoor
doaj +2 more sources
Haematological toxicity of midodrine in haemodialysis patients [PDF]
Nephrology Dialysis Transplantation, 2000 Hassane Izzedine +4 more
openalex +4 more sources
Utility of an alpha-1 adrenergic agonist in the management of chylothorax: a case series and management algorithm [PDF]
European Journal of Case Reports in Internal MedicineChylothorax is the accumulation of lymphatic fluid (chyle) within the pleural space. There are multiple causes, including traumatic and non-traumatic mechanisms.
Ruben Peralta +5 more
doaj +2 more sources
The Use of Midodrine in Patients With Advanced Heart Failure [PDF]
Congestive Heart Failure, 2009 In many patients, the treatment of heart failure (HF) cannot be optimized because of pre‐existing or treatment‐induced hypotension. Midodrine, a peripheral α1‐adrenergic agonist may allow for up‐titration of neurohormonal antagonist therapy leading to improved outcomes.
Ramzan M. Zakir +3 more
openalex +4 more sources
Midodrine initiation criteria, dose titration, and adverse effects when administered to treat shock: A systematic review and semi-quantitative analysis. [PDF]
J Crit Care Med (Targu Mures)Puissant MM +7 more
europepmc +2 more sources
Oral Midodrine as an Adjunct to Accelerate Vasopressor Liberation in Septic Shock: A Prospective Randomized Controlled Trial [PDF]
Indian J Crit Care MedANAS V +5 more
europepmc +2 more sources
Immune Checkpoint Inhibitor-Related Dysautonomia in Merkel Cell Carcinoma: A Case Report. [PDF]
Cancer Rep (Hoboken)ABSTRACT Background Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block inhibitory pathways that cancer cells exploit to suppress T‐cell activation. Although immune‐related adverse events (irAEs) linked to ICI therapy are well documented and encompass dermatologic, endocrine, gastrointestinal, hepatic, and neurologic systems, ICI ...
Kuchimanchi N +3 more
europepmc +2 more sources